ROSEN, LEADING INVESTOR COUNSEL, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation - YS, SMIH ...Middle East

NEW YORK, April 30, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. (NASDAQ: YS, SMIH). SO WHAT: If you...

Hence then, the article about rosen leading investor counsel encourages ys biopharma co ltd f k a summit healthcare acquisition corp investors to inquire about securities class action investigation ys smih was published today ( Monday 01/05/2023 - 01:40 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ROSEN, LEADING INVESTOR COUNSEL, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation - YS, SMIH )

Also on site :

• Golfer Masashi ‘Jumbo’ Ozaki dies at 78
• Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
• Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline